Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

RBC Capital Initiates Coverage On Privia Health Gr with Outperform Rating, Announces Price Target of $36

By Benzinga Newsdesk
Today, 8:05 PM
RBC Capital analyst Sean Dodge initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $36.

PRVA

Read More
2 minute read
  • Analyst Ratings

4 Analysts Have This to Say About Privia Health Group

By Benzinga Insights
Today, 8:05 PM
Analysts have provided the following ratings for Privia Health Group (NASDAQ:PRVA) within the last quarter: Bullish Somewhat Bullish…

PRVA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

UBS Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $30

By Benzinga Newsdesk
Today, 8:05 PM
UBS analyst Andrew Mok initiates coverage on Privia Health Group (NASDAQ:PRVA) with a Buy rating and announces Price Target of $30.

PRVA

Read More
2 minute read
  • Management
  • News

Reported Late Monday, NeoGenomics Announces Jeffrey S. Sherman Will Join The Company As Chief Financial Officer Effective December 7, Succeeding William Bonello Who Will Remain With The Company To Provide Transition And Onboarding Support For A Period…

By Benzinga Newsdesk
Today, 8:05 PM
Jeffrey S. Sherman Appointed Chief Financial Officer

NEO

Read More
3 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Short Sellers
  • Small Cap
  • Trading Ideas

Target, Holley, Ferroglobe And Other Big Losers From Wednesday

By Lisa Levin
Today, 8:05 PM
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.

AAP

Read More
2 minute read
  • News
  • Offerings

Reported Late Wednesday, Privia Health Announces Pricing Of Secondary Offering Of 5M Shares At A Price Of $23.50/Share

By Benzinga Newsdesk
Today, 8:05 PM
Privia Health Group, Inc. (NASDAQ:PRVA, or ", Privia Health", or the ", Company", )))) announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of common stock by

PRVA

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

BP To Rally Around 22%? Plus This Analyst Predicts $32 For Toast

By Lisa Levin
Today, 8:05 PM
 

BP

Read More
2 minute read
  • Analyst Ratings

Where Privia Health Group Stands With Analysts

By Benzinga Insights
Today, 8:05 PM
Over the past 3 months, 8 analysts have published their opinion on Privia Health Group (NASDAQ:PRVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

PRVA

Read More
1 minute read
  • News

Privia Health To Partner With OhioHealth Health System; Subject To Negotiation

By Benzinga Newsdesk
Today, 8:05 PM
ARLINGTON, Va., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA) and OhioHealth, a nationally recognized not-for-profit health system, today announced a non-binding memorandum of understanding to form

PRVA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Truist Securities Assumes Privia Health Group at Buy, Raises Price Target to $54

By Benzinga Newsdesk
Today, 8:05 PM
Truist Securities analyst Jailendra Singh assumes Privia Health Group (NASDAQ:PRVA) with a Buy rating and raises Price Target to $54.

PRVA

Posts navigation

1 2 … 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service